AAAAAA
Results:
1-11
|
Results: 11
Authors:
SCHULLER J
CZEJKA M
KREXNER E
LEHNER K
BUCHER H
SCHERNTHANER G
Citation: J. Schuller et al., PHARMACOKINETIC (PK) INTERACTION OF THE COMBINATION OF DOXORUBICIN (DOX) AND TAXOTERE (TXT), Annals of oncology, 9, 1998, pp. 607-607
Authors:
SCHULLER J
CZEJKA M
KREXNER E
SPRINGER B
EDER I
TERKOLA R
SCHEIBER B
Citation: J. Schuller et al., INFLUENCE OF PACLITAXEL (PAC) ON TOPOTECAN (TPT) PHARMACOKINETICS (PK) IN ADVANCED CANCER-PATIENTS, Annals of oncology, 9, 1998, pp. 633-633
Authors:
SCHULLER J
CZEJKA M
KREXNER E
PIETRZAK C
SPRINGER B
KLETZL H
BOROW D
Citation: J. Schuller et al., AMIFOSTINE (AMI) DIFFERENTLY INFLUENCES PHARMACOKINETICS (PK) OF SELECTED CYSTOSTATIC AGENTS (CY), European journal of cancer, 33, 1997, pp. 1109-1109
Authors:
PERNKOPF I
TESCH G
DEMPE K
KLETZL H
SCHULLER J
CZEJKA M
Citation: I. Pernkopf et al., BINDING OF EPIRUBICIN TO HUMAN PLASMA-PRO TEINS AND RED-BLOOD-CELLS -IN-VITRO INTERACTION WITH THE CYTOPROTECTANT AMIFOSTINE, Die Pharmazie, 51(11), 1996, pp. 897-901
Authors:
SCHULLER J
CZEJKA M
Citation: J. Schuller et M. Czejka, PHARMACOKINETIC INTERACTION OF 5-FLUOROURACIL AND INTERFERON-ALPHA-2BWITH OR WITHOUT FOLINIC ACID, Medical oncology, 12(1), 1995, pp. 47-53
Authors:
SCHULLER J
CZEJKA M
BANDAK S
BOROW D
PIETRZAK C
MAREI I
SCHERNTHANER G
Citation: J. Schuller et al., COMPARISON OF PHARMACOKINETICS (PK) OF FREE AND LIPOSOME-ENCAPSULATEDDOXORUBICIN IN ADVANCED CANCER-PATIENTS, European journal of cancer, 31A, 1995, pp. 959-959
Authors:
CZEJKA M
BANDAK S
SIMON D
SCHULLER J
WEISS C
SCHERNHAMMER E
Citation: M. Czejka et al., PHARMACOKINETIC INTERACTION BETWEEN 4'-EPIDOXORUBICIN AND THE MULTIDRUG-RESISTANCE REVERTING AGENT QUININE, Zeitschrift fur Naturforschung. C, A journal of biosciences, 50(7-8), 1995, pp. 565-570
Authors:
CZEJKA M
SCHULLER J
SCHERNHAMMER E
BANDAK S
Citation: M. Czejka et al., DRUG-INTERACTION BETWEEN INTERFERON-ALPHA -2B AND 5-FLUOROURACIL DURING CONTINUOUS INTRAVENOUS 5FU-INFUSION, Die Pharmazie, 50(6), 1995, pp. 416-419
PHARMACOKINETIC DRUG-INTERACTION BETWEEN EPIRUBICIN AND INTERFERON-A-2B IN SERUM AND RED-BLOOD-CELLS
Authors:
BANDAK S
CZEJKA M
SCHULLER J
SCHERNHAMMER E
Citation: S. Bandak et al., PHARMACOKINETIC DRUG-INTERACTION BETWEEN EPIRUBICIN AND INTERFERON-A-2B IN SERUM AND RED-BLOOD-CELLS, Arzneimittel-Forschung, 45-1(2), 1995, pp. 212-215
Authors:
BANDAK S
CZEJKA M
SCHULLER J
Citation: S. Bandak et al., IN-VITRO AND IN-VIVO BINDING OF EPIRUBICIN TO RED-BLOOD-CELLS AND HUMAN PLASMA-PROTEINS, Zeitschrift fur Naturforschung. C, A journal of biosciences, 49(7-8), 1994, pp. 483-488
Authors:
SCHEITHAUER W
SCHENK T
CZEJKA M
Citation: W. Scheithauer et al., PHARMACOKINETIC INTERACTION BETWEEN EPIRUBICIN AND THE MULTIDRUG-RESISTANCE REVERTING AGENT D-VERAPAMIL, British Journal of Cancer, 68(1), 1993, pp. 8-9
Risultati:
1-11
|